Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Precigen stock
Learn how to easily invest in Precigen stock.
Precigen is a biotechnology business based in the US. Precigen shares (PGEN) are listed on the NASDAQ and all prices are listed in US Dollars. Precigen employs 456 staff and has a trailing 12-month revenue of around $118.4 million.
How to buy Precigen stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – PGEN. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Easy to use platform with low fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
Precigen stock price (NASDAQ: PGEN)Use our graph to track the performance of PGEN stocks over time.
Precigen shares at a glance
|Latest market close||$1.83|
|52-week range||$1.12 - $2.90|
|50-day moving average||$1.69|
|200-day moving average||$1.75|
|Wall St. target price||$8.28|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.47|
Buy Precigen stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Precigen stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Precigen price performance over time
|1 week (2023-01-31)||12.96%|
|1 month (2023-01-06)||14.38%|
|3 months (2022-11-07)||15.09%|
|6 months (2022-08-05)||-11.59%|
|1 year (2022-02-07)||-17.94%|
|2 years (2021-02-05)||-77.41%|
|3 years (2020-02-07)||4.42|
|5 years (2018-02-07)||13.58|
|Revenue TTM||$118.4 million|
|Gross profit TTM||$-4,653,000|
|Return on assets TTM||-12.19%|
|Return on equity TTM||-51.32%|
|Market capitalisation||$456.8 million|
TTM: trailing 12 months
Precigen share dividends
We're not expecting Precigen to pay a dividend over the next 12 months.
Precigen share price volatility
Over the last 12 months, Precigen's shares have ranged in value from as little as $1.12 up to $2.9. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Precigen's is 1.8772. This would suggest that Precigen's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch, an inducible gene switch system that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; tissue-specific promoters; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc.
Precigen in the news
Germantown's Precigen raises $75M to advance treatments for rare diseases
Precigen Announces Closing of Public Offering of Common Stock
3 Penny Stocks That Could Make You Filthy Rich
Frequently asked questionsWhat percentage of Precigen is owned by insiders or institutions?
Currently 9.909% of Precigen shares are held by insiders and 55.276% by institutions. How many people work for Precigen?
Latest data suggests 456 work at Precigen. When does the fiscal year end for Precigen?
Precigen's fiscal year ends in December. Where is Precigen based?
Precigen's address is: 20374 Seneca Meadows Parkway, Germantown, MD, United States, 20876 What is Precigen's ISIN number?
Precigen's international securities identification number is: US74017N1054 What is Precigen's CUSIP number?
Precigen's Committee on Uniform Securities Identification Procedures number is: 74017N105
More guides on Finder
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert